Global /China /Healthcare /Drug Manufacturers - General /600080

Ginwa Enterprise (Group) Inc.

600080

• SSE: 600080 • Delayed

7.62CNY -5%

1.13 USD

As of 14 June 2026, Ginwa Enterprise (Group) Inc. has a market cap of $417.47M USD, ranking #16368 globally and #5128 in China. It ranks #1475 in the Healthcare sector, and #534 in the Drug Manufacturers - General industry.

Global Rank

16368

Country Rank

5128

Sector Rank

1475

Industry Rank

534

Key Stats

Market Cap

$417.47MUSD

2.83B CNY

Enterprise Value

$368.15MUSD

2.49B CNY

Revenue (TTM)

$80.29MUSD

544.04M CNY

EBITDA (TTM)

$2.77MUSD

18.74M CNY

Net Income (TTM)

$2.3MUSD

15.58M CNY

EBITDA Margin

3.4%

Profit Margin

2.9%

PE Ratio

181.4

PS Ratio

5.2

PB Ratio

1.8

EV/EBITDA

123.3

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Zhuojun Han open_in_new

Employees

588

Founded

1996

Website

ginwa.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-5%	-0.5%	-6.7%	0.6%	6.2%	6.4%	13%	4%	24%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	600080 金花企业(集团)股份有限公司 Class A ISIN: CNE000000QQ8 Shares Out.: Shares Outstanding: 352.712M¹ Shares Float: 335.883M² TV: TradingView: SSE: 600080 SA: Stock Analysis: SHA: 600080 YF: Yahoo Finance: 600080.SS GF: Google Finance: SHA: 600080 BA: Barron's: 600080 MS: Morningstar: XSHG: 600080	7.62 CNY	TV: TradingView: SSE: 600080 SA: Stock Analysis: SHA: 600080 YF: Yahoo Finance: 600080.SS GF: Google Finance: SHA: 600080 BA: Barron's: 600080 MS: Morningstar: XSHG: 600080

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Ginwa Enterprise (Group) Inc.

Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. It is also involved in the pharmaceutical logistics activities. The company was founded in 1996 and is headquartered in Xi'an, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 13K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 12K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 7K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 4K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 4K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 4K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 182K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 131K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 86K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 77K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 69K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 66K%	20.5	Switzerland

chevron_leftBack